View in EDS

Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.

Saved in:
Bibliographic Details
Title: Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
Authors: Hammerslag LR; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America. Electronic address: l.hammerslag@uky.edu., Talbert J; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America., Slavova S; Department of Biostatistics, College of Public Health, University of Kentucky, United States of America., Lei F; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America., Freeman PR; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America., Marks KR; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America., Fanucchi LC; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America., Walsh SL; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America., Lofwall MR; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America.
Source: Journal of substance use and addiction treatment [J Subst Use Addict Treat] 2024 Sep; Vol. 164, pp. 209391. Date of Electronic Publication: 2024 May 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918541186406676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2949-8759 (Electronic) Linking ISSN: 29498759 NLM ISO Abbreviation: J Subst Use Addict Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38740189
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hammerslag+LR%22">Hammerslag LR</searchLink>; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America. Electronic address: l.hammerslag@uky.edu.<br /><searchLink fieldCode="AU" term="%22Talbert+J%22">Talbert J</searchLink>; Institute for Biomedical Informatics, College of Medicine, University of Kentucky, United States of America; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America.<br /><searchLink fieldCode="AU" term="%22Slavova+S%22">Slavova S</searchLink>; Department of Biostatistics, College of Public Health, University of Kentucky, United States of America.<br /><searchLink fieldCode="AU" term="%22Lei+F%22">Lei F</searchLink>; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America.<br /><searchLink fieldCode="AU" term="%22Freeman+PR%22">Freeman PR</searchLink>; Department of Pharmacy Practice and Science, College of Pharmacy, University of Kentucky, United States of America.<br /><searchLink fieldCode="AU" term="%22Marks+KR%22">Marks KR</searchLink>; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America.<br /><searchLink fieldCode="AU" term="%22Fanucchi+LC%22">Fanucchi LC</searchLink>; Department of Internal Medicine, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America.<br /><searchLink fieldCode="AU" term="%22Walsh+SL%22">Walsh SL</searchLink>; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America.<br /><searchLink fieldCode="AU" term="%22Lofwall+MR%22">Lofwall MR</searchLink>; Department of Behavioral Science, College of Medicine, University of Kentucky, United States of America; Center on Drug and Alcohol Research, College of Medicine, University of Kentucky, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918541186406676%22">Journal of substance use and addiction treatment</searchLink> [J Subst Use Addict Treat] 2024 Sep; Vol. 164, pp. 209391. <i>Date of Electronic Publication: </i>2024 May 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918541186406676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2949-8759 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229498759%22">29498759 </searchLink><i>NLM ISO Abbreviation: </i>J Subst Use Addict Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38740189
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.josat.2024.209391
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 209391
    Titles:
      – TitleFull: Utilization of long-acting injectable monthly depot buprenorphine for opioid use disorder (OUD) in Kentucky, before and after COVID-19 related buprenorphine access policy changes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hammerslag LR
      – PersonEntity:
          Name:
            NameFull: Talbert J
      – PersonEntity:
          Name:
            NameFull: Slavova S
      – PersonEntity:
          Name:
            NameFull: Lei F
      – PersonEntity:
          Name:
            NameFull: Freeman PR
      – PersonEntity:
          Name:
            NameFull: Marks KR
      – PersonEntity:
          Name:
            NameFull: Fanucchi LC
      – PersonEntity:
          Name:
            NameFull: Walsh SL
      – PersonEntity:
          Name:
            NameFull: Lofwall MR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2024 Sep
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2949-8759
          Numbering:
            – Type: volume
              Value: 164
          Titles:
            – TitleFull: Journal of substance use and addiction treatment
              Type: main
ResultId 1